Screener
Nurix Therapeutics, Inc. NRIX Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The source filing: Nurix Therapeutics, Inc.’s 10-Q, filed July 9, 2026.
- Filed
- Jul 9, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001549595-26-000040
| Line item | May 31,2026 | November 30,2025 |
|---|---|---|
| Marketable securities | 375,844 | 345,981 |
| Prepaid expenses and other current assets | 12,952 | 13,878 |
| Total current assets | 456,481 | 606,819 |
| Operating lease right-of-use assets | 50,107 | 50,517 |
| Property and equipment, net | 20,007 | 22,490 |
| Restricted cash | 968 | 968 |
| Other assets | 7,977 | 7,341 |
| Total assets | $535,540 | $688,135 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Nurix Therapeutics, Inc.'s operating lease ROU assets?
- Nurix Therapeutics, Inc. (NRIX) reported operating lease ROU assets of $50.11M in Q1 2026.
- How has Nurix Therapeutics, Inc.'s operating lease ROU assets changed year-over-year?
- Nurix Therapeutics, Inc.'s operating lease ROU assets decreased by 0.2% year-over-year, from $50.21M to $50.11M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s operating lease ROU assets?
- Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s operating lease ROU assets has grown at a 30.5% compound annual growth rate (CAGR), from $13.34M to $50.52M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about Nurix Therapeutics, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude